August 14, 2026 02:23 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute | Netaji row explodes in Bengal: Suvendu Adhikari orders police action over ‘derogatory’ posts | Kolkata's NRS Hospital nurse found dead in washroom during night shift | RG Kar rape-murder case takes fresh turn as ex-TMC MLA Nirmal Ghosh arrested over cremation probe | ‘Govt has nothing to hide’: Amit Shah says ‘ready for debate’ on NEET crackdown; Rahul Gandhi hits back, ‘not interested in lecture’ | Tata Sons leadership shock: N Chandrasekaran won’t seek reappointment as chairman after February 2027 | ISI-linked Pakistani national arrested in Bengal over 'espionage' targeting Army, BSF, Railways

Vicks Action 500 Extra banned

| | Mar 15, 2016, at 06:12 pm
Mumbai, Mar 15 (IBNS) After Corex and Phensedyl it is now Vicks Action 500 Extra as FMCG major Procter and Gamble (P&G) has discontinued manufacture and sale of its popular brand of cold and flu pill with immediate effect after the government banned fixed dose combination drugs.
 "The Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination drugs (Paracetamol + Phenylephrine + Caffeine) with immediate effect," Pfizer   said in a BSE filing.
 
 "Our product 'Vicks Action 500 Extra' has the same fixed dose combination and gets covered under notification. we have discontinued the manufacture and sale of all SKUs of 'Vicks Action 500 Extra with immediate effect." 
 
On Monday,  Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively, after the government banned over 300 fixed dose combinations (FDCs) drugs. 
 
Corex had garnered sales of Rs 176 crore in the nine-month period ended December 31. Pfizer admitted that the  government's move will have an adverse impact on it. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.